Skip navigation

Navigate Drug Sample Reporting Requirements Under Sunshine and Optimize Operations for Greater Market Access

October 16-17, 2019
  • Philadelphia, PA

CBI’s 9th annual Next Generation Pharmaceutical Samples returns as the preeminent forum to discuss best practices in physician sample programs. Benefit from compelling content that addresses the biggest emerging issues in sample programs and chart your program growth for 2019 and beyond. This year’s program will look closely at staff training, data priorities, analytics, audits & inspections, state level regulations, emerging technologies, the changing federal landscape and global sample programs.

CONTENT HIGHLIGHTS FOR 2019:

  • Gain state-to-state updates on changing sample rules
    and regulations
  • Develop best practices in running a robust and compliant
    global sample program
  • Evaluate emerging technologies to enhance the effectivity of
    your sample programs including sales analytics tools
  • Enhance your data strategies by determining which data sets
    take priority, learning how to capture it, and how to gain
    actionable insights from it
  • Learn techniques in staff training to ensure your staff quickly
    gets up to speed, remains compliant and continues to improve
  • Discover the anatomy of the sample audit program and stay
    ahead of penalties with mock audits and inspections
  • Explore techniques for inventory management and control

Download the Conference Preview

Previous Attendee Acclaim:

Loved the group discussion segments. Also enjoyed that the day had plenty of time built in to
actually network with people.

Janssen Pharmaceuticals

Interactive and very engaging.

Jebela Pharmaceuticals Inc.

Next Generation Pharmaceutical Samples

Navigate Drug Sample Reporting Requirements Under Sunshine and Optimize Operations for Greater Market Access

CBI’s 9th annual Next Generation Pharmaceutical Samples returns as the preeminent forum to discuss best practices in physician sample programs. Benefit from compelling content that addresses the biggest emerging issues in sample programs and chart your program growth for 2019 and beyond. This year’s program will look closely at staff training, data priorities, analytics, audits & inspections, state level regulations, emerging technologies, the changing federal landscape and global sample programs.

CONTENT HIGHLIGHTS FOR 2019:

  • Gain state-to-state updates on changing sample rules
    and regulations
  • Develop best practices in running a robust and compliant
    global sample program
  • Evaluate emerging technologies to enhance the effectivity of
    your sample programs including sales analytics tools
  • Enhance your data strategies by determining which data sets
    take priority, learning how to capture it, and how to gain
    actionable insights from it
  • Learn techniques in staff training to ensure your staff quickly
    gets up to speed, remains compliant and continues to improve
  • Discover the anatomy of the sample audit program and stay
    ahead of penalties with mock audits and inspections
  • Explore techniques for inventory management and control

Download the Conference Preview

Previous Attendee Acclaim:

Loved the group discussion segments. Also enjoyed that the day had plenty of time built in to
actually network with people.

Janssen Pharmaceuticals

Interactive and very engaging.

Jebela Pharmaceuticals Inc.